Skip to main content
. 2019 Dec 27;71(12):3110–3117. doi: 10.1093/cid/ciz1213

Figure 3.

Figure 3.

Human Immunodeficiency Virus Treatment Satisfaction Questionnaire status version (HIVTSQs) scores at weeks 4, 24, and 48 after rapid initiation of darunavir/cobicistat/emtricitabine/tenofovir alafenamide. A, Total HIVTSQs scores. B, HIVTSQs subscale scores. aHigher scores indicate greater satisfaction. Abbreviation: SE, standard error.